Yttrium-90 Internal Radiation Therapy as Part of the Multimodality Treatment of Metastatic Colorectal Carcinoma
Onco · 2021
DOI: 10.3390/onco1020015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Onco, 2021. Verfasst von Michael P. Del Rosario und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
About 70% of patients with metastatic colorectal carcinoma (mCRC) have liver metastases. Hepatic failure accounts for most mCRC-related deaths. Therefore, controlling liver metastases may improve outcomes. A data overview of liver-directed treatment using yttrium-90 selective internal radiation therapy (SIRT) is provided as part of a multimodality treatment. SIRT in mCRC is discussed, and the prognostic factors for patient selection are defined. Pooled analyses of three recent trials incorporating SIRT plus chemotherapy revealed subsets of patients with mCRC who might benefit from SIRT. A multidisciplinary treatment for most mCRC patients is proposed to achieve long-term survival in this cohort of patients.
Zitieren
APA
Rosario, M. P. D., Abi-Jaoudeh, N., Cho, M. T., Jutric, Z., & Dayyani, F. (2021). Yttrium-90 Internal Radiation Therapy as Part of the Multimodality Treatment of Metastatic Colorectal Carcinoma. Onco. https://doi.org/10.3390/onco1020015
Vancouver
Rosario MPD, Abi-Jaoudeh N, Cho MT, Jutric Z, Dayyani F. Yttrium-90 Internal Radiation Therapy as Part of the Multimodality Treatment of Metastatic Colorectal Carcinoma. Onco. 2021. doi:10.3390/onco1020015
BibTeX
@article{Rosario2021,
author = {Rosario, Michael P. Del and Abi-Jaoudeh, Nadine and Cho, May T. and Jutric, Zeljka and Dayyani, Farshid},
title = {Yttrium-90 Internal Radiation Therapy as Part of the Multimodality Treatment of Metastatic Colorectal Carcinoma},
journal = {Onco},
year = {2021},
doi = {10.3390/onco1020015}
}
EUVIMED